Over the 30 years that Interpath Services has supplied the Australian market with a comprehensive range of pre-analytical and diagnostic products, we have experienced previous infectious disease emergencies that we have responded to.
The level of demand that we have experienced in the last 3-4 weeks in response to the COVID-19 pandemic has never been experienced before-it is unprecedented in our time of operation. We are doing whatever we can to maintain supply, understanding the critical nature of many of the products concerned.
Simply, for many products particularly swabs, demand is far exceeding what we can supply. The same applies to our global manufacturer of these swabs who is operating on a 24/7 basis and is at maximum capacity, responding to worldwide demand. We had already significantly increased our orders for swabs, but the extenuating world circumstances mean that we receive an allocation based on factors including population of the country, number of COVID-19 positive cases in the country and number of actual tests performed on a weekly basis in the country.
Our priority during this coronavirus outbreak is to maintain supply to our existing customers with a fair and equitable allocation of stock amongst all customers who have previously bought the products that they are now seeking. A similar approach will be applied to orders we receive for non-swab products as we are seeing significant increases in demand for these as well.
Our Sales and Customer Service Teams are being inundated with orders, requests and enquiries and we have diverted our entire Sales and Administration Teams from their normal activities to assist in our speed of response to customers during this emergency.
We thank you for your continued support. Be assured we are taking whatever action we realistically can to maintain supply and provide a high level of responsiveness. The situation is very fluid, and reality is that we cannot look more than 1-2 days ahead at present.
Interpath Services Management